CoChat

Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells

Open access

Published version of a preprint

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Abstract

Therapeutics that induce cancer cell senescence can block cell proliferation and promote immune rejection. However, the risk of tumor relapse due to senescence escape may remain high due to the long lifespan of senescent cells that are not cleared. Here, we show how combining a senescence-inducing inhibitor of the mitotic kinase Aurora A (AURKA) with an MDM2 antagonist activates p53 in senescent tumors harboring wild-type 53. In the model studied, this effect is accompanied by proliferation arrest, mitochondrial depolarization, apoptosis, and immune clearance of cancer cells by antitumor leukocytes in a manner reliant upon Ccl5, Ccl1, and Cxcl9. The AURKA/MDM2 combination therapy shows adequate bioavailability and low toxicity to the host. Moreover, the prominent response of patient-derived melanoma tumors to coadministered MDM2 and AURKA inhibitors offers a sound rationale for clinical evaluation. Taken together, our work provides a preclinical proof of concept for a combination treatment that leverages both senescence and immune surveillance to therapeutic ends.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-14-2405

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 116

Metadata

Authors
Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., Turner, D. C., Essaka, D. C., Stewart, C. F., Sosman, J. A., Kelley, M. C., Ecsedy, J. A., Johnston, J. N., & Richmond, A.
Affiliations
  • VA Tennessee Valley Healthcare System (US)
  • Vanderbilt University (US)
  • Meharry Medical College (US)
  • Vanderbilt University Medical Center (US)
  • St. Jude Children's Research Hospital (US)
  • 11Takeda Pharmaceuticals International Co., Cambridge, Massachusetts.
Corresponding author
Richmond, Ann
Venue
Cancer Research
Published
2015-01-01
Volume
75
Issue
1
Pages
181-193
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2113591516
Cited by
115
References
51
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 10 · 2022: 11 · 2021: 32 · 2020: 12 · 2019: 6 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 6
FWCI
3.38
Type
journal article
Language
en
Open access
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Veterans Affairs (I01BX002301, IK6 BX005225, I01 BX000196)
  • Innovative Research Group Project of the National Natural Science Foundation of China
  • National Institutes of Health
  • National Cancer Institute (CA 116021, F32CA171895, CA-90625, R01CA116021, R01CA034590, K12CA090625, T32CA119925, P30CA068485, P30CA021765, CA116021-S1)
  • National Institute of General Medical Sciences (R01GM084333)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
melanoma, MDM2 inhibitors, Aurora A kinase inhibitor, senescence, p53 activation, apoptosis, tumor surveillance, mitochondrial depolarization, chemokines, RANTES, CCL1, CXCL9, combination therapy, senescence escape
MeSH terms
Animals, Antineoplastic Combined Chemotherapy Protocols, Azepines, Humans, Imidazoles, Melanoma, Melanoma, Experimental, Mice, Inbred BALB C, Mice, Inbred C57BL, Mice, Nude, Piperazines, Pyrimidines, Apoptosis, Protein Kinase Inhibitors, Cell Proliferation, Proto-Oncogene Proteins c-mdm2, Aurora Kinase A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-14-2405
The paper
Vilgelm, A. E., Pawlikowski, J. S., Liu, Y., Hawkins, O. E., Davis, T. A., Smith, J., Weller, K. P., Horton, L. W., McClain, C. M., Ayers, G. D., Turner, D. C., Essaka, D. C., Stewart, C. F., Sosman, J. A., Kelley, M. C., Ecsedy, J. A., Johnston, J. N., & Richmond, A. (2015). Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-14-2405

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.